Pleural decortication and hyperthermic intrathoracic chemotherapy for pseudomyxoma

Int J Hyperthermia. 2022;39(1):1153-1157. doi: 10.1080/02656736.2022.2104938.

Abstract

Aim: Pleural dissemination of pseudomyxoma peritonei (PMP) is an extremely rare diagnosis, for which no standard therapy is available.Methods: We describe the successful treatment of a 67-year-old male diagnosed with left-sided intrapleural dissemination of PMP (low-grade appendiceal mucinous neoplasm), 2 years after treatment of abdominal PMP with cytoreductive surgery (CRS) and hyperthermic intra-peritoneal chemotherapy. Treatment consisted of extended pleural decortication (ePD) and oxaliplatin-based hyperthermic intrathoracic chemotherapy (HITHOC). The patient is doing well without complications or signs of recurrence, 26 months after thoracic surgery.Conclusion: ePD in combination with HITHOC is a valuable treatment for thoracic PMP.

Keywords: HITHOC; pleural decortication; pseudomyxoma peritonei.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Appendiceal Neoplasms* / therapy
  • Combined Modality Therapy
  • Cytoreduction Surgical Procedures
  • Humans
  • Hyperthermia, Induced*
  • Male
  • Peritoneal Neoplasms* / diagnostic imaging
  • Peritoneal Neoplasms* / drug therapy
  • Peritoneal Neoplasms* / surgery
  • Pseudomyxoma Peritonei* / diagnostic imaging
  • Pseudomyxoma Peritonei* / drug therapy
  • Pseudomyxoma Peritonei* / surgery
  • Retrospective Studies